What is Melanotan I?
Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxicity in people with erythropoietic protoporphyria (EPP).
Also known as: MT-1, Afamelanotide, Scenesse
How Melanotan I is studied
Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxic reactions in people with erythropoietic protoporphyria (EPP) by increasing protective pigmentation.
Commonly researched for
Research status
Important considerations
The approved form is prescription-only for EPP. Unregulated tanning use is not medically endorsed.
Melanotan I — frequently asked questions
As afamelanotide (Scenesse), it is approved to reduce phototoxicity in people with erythropoietic protoporphyria (EPP).
No. Melanotan I has an approved clinical form for a specific condition; Melanotan II is broader-acting and not approved.
The approved form is prescription-only for EPP. Unregulated cosmetic use is not medically endorsed.